In light of this, as the first study evaluating the usage of CCR5 serum levels in terms of the diagnosis of GC, we found that CCR5 levels correlated with the diagnosis of GC (p < 0.001, r = −0.449), and median serum levels of CCR5 were higher in the GC group than the controls. Here, CCR5 is linked to gastric cancer.